» Articles » PMID: 33743175

Integrative Opioid-GABAergic Neuronal Mechanisms Regulating Dopamine Efflux in the Nucleus Accumbens of Freely Moving Animals

Overview
Journal Pharmacol Rep
Specialty Pharmacology
Date 2021 Mar 20
PMID 33743175
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The nucleus accumbens (NAc) is a terminal region of mesocorticolimbic dopamine (DA) neuronal projections from the ventral tegmental area. Accumbal DA release is integrated by afferents from other brain regions and by interneurons, which involve a diversity of neurotransmitters and neuropeptides. These integrative processes, implicated in the pathobiology of neuropsychiatric disorders, are mediated via receptor subtypes whose relative roles in the regulation of accumbal DA release are poorly understood. Such complex interactions are exemplified by how selective activation of opioid receptor subtypes enhances accumbal DA efflux in a manner that is modulated by changes in neural activity through GABA receptor subtypes. This review delineates the roles of GABA and GABA receptors in GABAergic neural mechanisms in NAc that participate in delta- and mu-opioid receptor-mediated increases in accumbal DA efflux in freely moving rats, focusing on studies using in vivo brain microdialysis. First, we consider how endogenous GABA exerts inhibition of accumbal DA efflux through GABA receptor subtypes. We also consider possible intra-neuronal source of the endogenous GABA that inhibits accumbal DA efflux. As NAc contains GABAergic neurons that express delta- or mu-opioid receptors, inhibition of accumbal GABAergic neurons is a candidate for mediating delta- or mu-opioid receptor-mediated increases in accumbal DA efflux. Therefore, we provide a detailed analysis of the effects of GABA receptor subtype ligands on delta- and mu-opioid receptor-mediated accumbal DA efflux. Finally, we present an integrative model to explain the mechanisms of interaction among delta- and mu-opioid receptors, GABAergic neurons and DAergic neurons in NAc.

Citing Articles

Endocannabinoid agonist 2-arachidonoylglycerol differentially alters diurnal activity and sleep during fentanyl withdrawal in male and female mice.

Gamble M, Miracle S, Williams B, Logan R Pharmacol Biochem Behav. 2024; 240:173791.

PMID: 38761993 PMC: 11166043. DOI: 10.1016/j.pbb.2024.173791.


Oxycodone-induced dopaminergic and respiratory effects are modulated by deep brain stimulation.

Yuen J, Goyal A, Rusheen A, Kouzani A, Berk M, Kim J Front Pharmacol. 2023; 14:1199655.

PMID: 37408764 PMC: 10318172. DOI: 10.3389/fphar.2023.1199655.

References
1.
Di Chiara G . Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Behav Brain Res. 2002; 137(1-2):75-114. DOI: 10.1016/s0166-4328(02)00286-3. View

2.
Nicola S . The nucleus accumbens as part of a basal ganglia action selection circuit. Psychopharmacology (Berl). 2006; 191(3):521-50. DOI: 10.1007/s00213-006-0510-4. View

3.
Floresco S . The nucleus accumbens: an interface between cognition, emotion, and action. Annu Rev Psychol. 2014; 66:25-52. DOI: 10.1146/annurev-psych-010213-115159. View

4.
Castro D, Bruchas M . A Motivational and Neuropeptidergic Hub: Anatomical and Functional Diversity within the Nucleus Accumbens Shell. Neuron. 2019; 102(3):529-552. PMC: 6528838. DOI: 10.1016/j.neuron.2019.03.003. View

5.
Di Chiara G, Bassareo V, Fenu S, De Luca M, Spina L, Cadoni C . Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology. 2004; 47 Suppl 1:227-41. DOI: 10.1016/j.neuropharm.2004.06.032. View